News
17h
Zacks Investment Research on MSNBioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...
List today: Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year ...
BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 29th: GDS Holdings Limited GDS: This data center operator from China has a Zacks Rank #1 ...
New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...
MAINZ, Germany, November 4, 2024-- BioNTech SE today reported financial results for the three and nine months ended September 30, 2024 and provided an update on its corporate progress. Ugur Sahin ...
A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
In adults 18 years of age and older, Comirnaty Omicron XBB.1.5, Comirnaty JN.1 and Comirnaty KP.2 may be administered concomitantly with a pneumococcal conjugated vaccine (PCV). an unadjuvanted ...
--BioNTech SE today reported financial results for the three and six months ended June 30, 2023, and provided an update on its corporate progress. Ugur Sahin, M.D., CEO and Co-Founder of BioNTech ...
Last March, when BioNTech—suddenly famous for developing a COVID-19 vaccine along with partner Pfizer—reported its revenue for 2020, it became clear what a shoestring budget the German biotech was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results